home / stock / cslly / cslly news


CSLLY News and Press, CSL Ltd ADR From 10/13/23

Stock Information

Company Name: CSL Ltd ADR
Stock Symbol: CSLLY
Market: OTC

Menu

CSLLY CSLLY Quote CSLLY Short CSLLY News CSLLY Articles CSLLY Message Board
Get CSLLY Alerts

News, Short Squeeze, Breakout and More Instantly...

CSLLY - Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment

2023-10-13 16:37:00 ET Summary Haemonetics has outperformed the medical device sector, with shares up 7% on very strong revenue growth in plasma collection and good margin leverage. The recent acquisition of OpSens expands Haemonetics' Hospital product portfolio; a specialty guide...

CSLLY - New Data Presented at IDWeek 2023 Demonstrates Public Health Benefit and Cost Savings Associated with Cell-Based and Adjuvanted Influenza Vaccines

New Data Presented at IDWeek 2023 Demonstrates Public Health Benefit and Cost Savings Associated with Cell-Based and Adjuvanted Influenza Vaccines PR Newswire Data evaluating the impact of cell-based quadrivalent influenza vaccines suggests an additional 31%–39% of in...

CSLLY - FDA experts recommend changes to flu vaccines

2023-10-05 15:26:42 ET More on GSK GSK: Strong Positioning And Trading At Historical Discount Merck Vs. GSK: The Game-Changer Race In Pharma Excellence GSK plc (GSK) BofA Global Healthcare Conference (Transcript) GSK to trim Haleon stake in over $1B share sal...

CSLLY - uniQure to cut over 50% of research projects in strategic review

2023-10-05 07:59:37 ET More on uniQure uniQure: AMT-130 Data And Other Catalysts In H2 2023 uniQure: The AMT-130 Readout uniQure cleared to start U.S. trial for gene therapy Seeking Alpha’s Quant Rating on uniQure Historical earnings data for u...

CSLLY - Expected US Company Earnings on Wednesday, September 27th, 2023

Nabriva Therapeutics plc (NBRVF) is expected to report for Q2 2023 JFE Holdings, Inc. (JFEEF) is expected to report for Q1 2024 Superior Gold Inc (SUPGF) is expected to report for Q2 2023 S&W Seed Company (SANW) is expected to report $-0.09 for Q4 2023 Jefferies Financial Grou...

CSLLY - Travere falls after Phase 3 data for kidney disease candidate

2023-09-21 08:04:57 ET More on CSL, Travere, etc. CSL: Watch Out For Positive Surprises CSL Limited (CSLLY) Q4 2023 Earnings Call Transcript Travere Boosts Cash Position As Investors Brace For Filspari Data Travere Therapeutics, Inc. (TVTX) Q2 2023 Earnings C...

CSLLY - Expected US Company Earnings on Wednesday, September 20th, 2023

Westbury Bancorp Inc (WBBW) is expected to report for quarter end 2023-06-30 Sumitomo Heavy Industries Ltd. ADR (SOHVY) is expected to report for Q1 2024 Belgravia Hartford Capital Inc (BLGVF) is expected to report for Q2 2023 Yasheng Group (HERB) is expected to report for Q2 2023 ...

CSLLY - CSL Seqirus Presents Real-World Evidence at ESWI Demonstrating the Impact of Influenza Vaccination Campaigns to Help Protect People and Healthcare Systems

CSL Seqirus Presents Real-World Evidence at ESWI Demonstrating the Impact of Influenza Vaccination Campaigns to Help Protect People and Healthcare Systems PR Newswire Results from a retrospective cohort study from 2015 to 2020 demonstrated a notable rise with increasing age ...

CSLLY - The 'tripledemic' threat to be less severe this season

2023-09-17 12:00:54 ET The impact of COVID, flu, and RSV on U.S. and U.K. hospitals is expected to be lower this winter compared to last, as there won't be a significant overlap between peak outbreaks of infections, the London-based data analytics firm Airfinity said in a recent report. ...

CSLLY - Expected US Company Earnings on Wednesday, September 13th, 2023

Software AG ADR (STWRY) is expected to report for Q2 2023 Dai Nippon Printing Co Ltd ADR (DNPLY) is expected to report for quarter end 2023-06-30 Coffee Holding Co. Inc. (JVA) is expected to report for Q1 2024 Calloway`s Nursery, Inc. (CLWY) is expected to report for Q2 2023 Home ...

Previous 10 Next 10